LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 15.58 | 27.76 | 1265 | 685 | 1.8452 | 1.2832 | MN20160318_Q01 | L18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 15.58 | 27.76 | 57 | 685 | 0.0831 | 0.1683 | MN20160318_Q01 | M15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 15.58 | 27.76 | 1244 | 685 | 1.8145 | 1.2749 | MN20160318_Q01 | M15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 17.28 | 27.76 | 39 | 838 | 0.0465 | 0.0716 | MN20160318_Q01 | L18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 17.28 | 27.76 | 1363 | 838 | 1.6251 | 1.2076 | MN20160318_Q01 | L18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 17.28 | 27.76 | 75 | 838 | 0.0894 | 0.2240 | MN20160318_Q01 | M15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 17.28 | 27.76 | 1291 | 838 | 1.5393 | 1.1834 | MN20160318_Q01 | M15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 18.98 | 27.76 | 56 | 941 | 0.0595 | 0.1480 | MN20160318_Q01 | L18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 18.98 | 27.76 | 1498 | 941 | 1.5917 | 1.1915 | MN20160318_Q01 | L18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 18.98 | 27.76 | 98 | 941 | 0.1041 | 0.2817 | MN20160318_Q01 | M15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 18.98 | 27.76 | 1378 | 941 | 1.4642 | 1.1558 | MN20160318_Q01 | M15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 20.68 | 27.76 | 69 | 1119 | 0.0617 | 0.1862 | MN20160318_Q01 | L18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 20.68 | 27.76 | 1606 | 1119 | 1.4352 | 1.1402 | MN20160318_Q01 | L18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 20.68 | 27.76 | 129 | 1119 | 0.1153 | 0.3338 | MN20160318_Q01 | M15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 20.68 | 27.76 | 1565 | 1119 | 1.3986 | 1.1298 | MN20160318_Q01 | M15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 22.39 | 27.76 | 91 | 1305 | 0.0697 | 0.2383 | MN20160318_Q01 | L18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 22.39 | 27.76 | 1712 | 1305 | 1.3112 | 1.0999 | MN20160318_Q01 | L18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 22.39 | 27.76 | 176 | 1305 | 0.1348 | 0.3944 | MN20160318_Q01 | M15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 22.39 | 27.76 | 1714 | 1305 | 1.3127 | 1.1004 | MN20160318_Q01 | M15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.09 | 27.76 | 108 | 1461 | 0.0739 | 0.2682 | MN20160318_Q01 | L18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.09 | 27.76 | 1884 | 1461 | 1.2890 | 1.0908 | MN20160318_Q01 | L18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.09 | 27.76 | 207 | 1461 | 0.1416 | 0.4210 | MN20160318_Q01 | M15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.09 | 27.76 | 1849 | 1461 | 1.2650 | 1.0839 | MN20160318_Q01 | M15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 25.79 | 27.76 | 130 | 1605 | 0.0810 | 0.3018 | MN20160318_Q01 | L18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 25.79 | 27.76 | 2044 | 1605 | 1.2734 | 1.0843 | MN20160318_Q01 | L18 |